Managing Multimorbidity 2023 – Polypharmacy and deprescribing – how to proceed? (Recorded webinar)
This 1-hour case-based, on-demand webinar discusses practical strategies for managing polypharmacy in an elderly patient with complex comorbidities and how best to move forward with deprescibing some of the medications for improved patient outcomes.
JAK inhibitors’ place in therapy for atopic dermatitis and alopecia areata
Take part in these interactive ACCME-accredited continuing professional development course to help understand the immunological pathways in the pathogenesis of atopic dermatitis and alopecia areata and the latest scientific data for emerging agents for atopic dermatitis and alopecia areata, particularly the janus kinase (JAK) inhibitor class of therapies.
Choose to view, short, selected highlights from the PARTNER Symposium, where rheumatologists and dermatologists met to discuss challenges and new practices in managing psoriasis and psoriatic arthritis.